Keyphrases
Vaccination
100%
Solid Malignancies
100%
Antineoplastic Drugs
100%
COVID-19 Vaccine
100%
BNT162b2
100%
Cancer Patients
75%
Healthy Individuals
50%
Chemotherapy
50%
Humoral Response
50%
Group by
25%
Highly Effective
25%
Risk Reduction
25%
Second Dose
25%
Multivariate Analysis
25%
In Cancer
25%
Odds Ratio
25%
Anticancer Therapy
25%
Little Data
25%
Non-cancer
25%
Negative Serology
25%
Group of Twenty
25%
Reduced Immunogenicity
25%
Patients with Chronic Diseases
25%
Protective Measures
25%
IgG Levels
25%
COVID-19 Risk
25%
COVID-19 Infection
25%
BNT162b2 Vaccine
25%
Medicine and Dentistry
Malignant Neoplasm
100%
Cancer
100%
Anticarcinogen
100%
Humoral Immunity
28%
Infection
14%
Odds Ratio
14%
Multivariate Analysis
14%
Cancer Treatment
14%
Chronic Disease
14%
Antiinfective Agent
14%
Immunogenicity
14%
COVID-19
14%
COVID-19 Vaccine
14%
Immunology and Microbiology
Vaccine Efficacy
100%
Vaccination Policy
100%
Humoral Immunity
50%
COVID-19
50%
Serology
25%
Immunogenicity
25%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Anticarcinogen
100%
Vaccination Policy
50%
Chemotherapy
25%
Infection
12%
Antiinfective Agent
12%
Chronic Disease
12%
Immunogenicity
12%
COVID-19 Vaccine
12%
Biochemistry, Genetics and Molecular Biology
Humoral Immunity
100%
Multivariate Analysis
50%
Immunogenicity
50%
Serology
50%